HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mayumi Hara Selected Research

Immunotherapy

6/2008Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mayumi Hara Research Topics

Disease

3Neoplasms (Cancer)
06/2008 - 05/2005
2Frailty
10/2021 - 11/2018
1Brain Diseases (Brain Disorder)
11/2020
1Brain Edema (Cerebral Edema)
11/2020
1Cognitive Dysfunction
02/2020
1Dementia (Dementias)
02/2020
1Hypotension (Low Blood Pressure)
10/2018
1Respiratory Sounds (Crackle)
10/2018
1Chronic Cough
10/2018
1Common Cold
10/2018
1Urticaria (Hives)
10/2018
1Anaphylaxis (Anaphylactic Shock)
10/2018
1Erythema
10/2018
1Vomiting
10/2018
1Thrombocytopenia (Thrombopenia)
02/2018
1Leukopenia
02/2018
1Melanoma (Melanoma, Malignant)
06/2008
1Experimental Melanoma
06/2008
1Carcinogenesis
05/2005

Drug/Important Bio-Agent (IBA)

1Phosphocreatine (Neoton)IBA
11/2020
1N-acetylaspartate (N-acetyl aspartate)IBA
11/2020
1Choline (Choline Chloride)IBA
11/2020
1CreatineIBA
11/2020
1Glutamine (L-Glutamine)FDA Link
11/2020
1Inositol (Myoinositol)IBA
11/2020
1Glutamic Acid (Glutamate)FDA Link
11/2020
1Vasopressins (Vasopressin)IBA
11/2020
1Indicators and Reagents (Reagents)IBA
11/2018
1Pharmaceutical PreparationsIBA
10/2018
1Antitussive Agents (Antitussives)FDA Link
10/2018
1tipepidineIBA
10/2018
1EnzymesIBA
02/2018
1Fas Ligand Protein (Fas Ligand)IBA
06/2008
1DepsipeptidesIBA
06/2008
1LuciferasesIBA
05/2008
1Luminescent ProteinsIBA
05/2008
1Green Fluorescent ProteinsIBA
05/2008
1ThrombomodulinIBA
05/2005
1ThrombinFDA Link
05/2005

Therapy/Procedure

1Long-Term Care
10/2021
1Activities of Daily Living (ADL)
02/2020
1Immunotherapy
06/2008